Next Article in Journal
Anti-Pollution Activity, Antioxidant and Anti-Inflammatory Effects of Fermented Extract from Smilax china Leaf in Macrophages and Keratinocytes
Next Article in Special Issue
Low-Molecular-Weight Gels as Smart Materials for the Enhancement of Antioxidants Activity
Previous Article in Journal
The Advancement of Herbal-Based Nanomedicine for Hair
Previous Article in Special Issue
A Review of Moisturizing Additives for Atopic Dermatitis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Biochemical Properties and Cosmetic Uses of Commiphora myrrha and Boswellia serrata

by
Bssmah Ghazi Alraddadi
1 and
Hyun-Jae Shin
1,2,*
1
Department of Beauty and Cosmetology, Graduate School of Industrial Technology Startup, Chosun University, 309 Pilmun-daero, Dong-gu, Gwangju 61452, Korea
2
Department of Biochemical Engineering, Chosun University, 309 Pilmun-daero, Dong-gu, Gwangju 61452, Korea
*
Author to whom correspondence should be addressed.
Cosmetics 2022, 9(6), 119; https://doi.org/10.3390/cosmetics9060119
Submission received: 25 October 2022 / Revised: 3 November 2022 / Accepted: 10 November 2022 / Published: 12 November 2022
(This article belongs to the Special Issue Active Substances and Bioavailability in Cosmetics)

Abstract

:
Organic materials have been the subject of numerous recent cosmetics studies. Plant extracts and/or plant-derived resources in the Middle East have significant potential in many cosmetic fields because they exhibit useful properties that promote the repair of cellular functions and improve skin conditions. Multiple organic substances from these resources have long-lasting environmental effects, extensive storage capacities, and affect human physiological activity. Recent studies have revealed that Commiphora myrrha (myrrh) and Boswellia serrata (frankincense) extracts can prevent aging, acne, and spots while enhancing skin moisture and suppleness. Given that myrrh and frankincense exhibit anti-inflammatory and antioxidant characteristics that significantly improve human health, their utilization in various cosmetic products has received attention from global cosmetic corporations. This review details the bioactive compounds and cosmeceutical properties of myrrh and frankincense and their use in cosmetic formulations.

1. Introduction

Since antiquity, plants have been utilized in cosmetics and have been the focus of modern scientific research. Drawing increasingly complex images has become possible because of the improved understanding of the skin and plants over time. Plants are sophisticated organisms that respond to their surroundings by producing various metabolites. Phytomolecules applied to the skin affects skin cells and influences the health and appearance of the skin. Physicochemical and ethnobotanical studies have identified various plants with the potential to improve contemporary cosmetic products [1]. Plants provide high-value active compounds for medicinal and aesthetic purposes. Targeted at improving skin problems and appearance, humans have utilized plants for thousands of years, which have been developed into modern cosmetics. The skin serves as the body’s interface to the exterior world and actively defends against threats. Therefore, the ability of plants to produce chemicals that can protect and calm the skin is essential. Modern cosmetics can adjust skin elasticity in addition to hydrating the skin and reducing redness [2].
The family Burseraceae contains about 18 genera, an estimated 560–600 species [3,4]. Since antiquity, these species have been used for their aromatic properties and medicinal applications. Thus, their spruce trees and shrubs often play a prominent role in the ethnobotany of their surrounding environment. Although the Burseraceae species are spread worldwide, studies and information are limited to the genera in Asia and Africa, such as Commiphora (myrrh), Canarium (incense elemi), and Boswellia (frankincense). Indigenous tribes have employed the resins of this species for various uses in traditional medicine, including its application as an external agent (cosmetics), for treating wounds (dressings), preventing the deterioration of extremities and broken teeth, or as an antiseptic and disinfectant. Moreover, inhaling the smoke can induce anesthetic effects [5].
This review aims to introduce C. Myrrha and B. Serrata and determine their chemical composition, their activities as antioxidants, antimicrobials, and anti-inflammatories, as well as their influential role in promoting health in the human body. Specifically, and especially, their effective activity against acne and wrinkles, and many of the excellent effects and higher values of these plants in cosmetics.

2. Commiphora myrrha

The Commiphora species has high medical importance. It abounds mostly under mountains and in rocky settings in Saudi Arabia, notably east of Tihama [6,7]. Commiphora forms a particular element of Saudi flora [6], and its trees are spread on the sands of the Red Sea, west and southwest of the Kingdom of Saudi Arabia (KSA). They have a wide ecological range between 1 and 2100 m above sea level and are found in tropical and semi-tropical areas [6,7,8,9]. They are also found in Somalia [6,7,8,9,10,11]. Some species are located mainly in Africa (specifically in Ethiopia, Somalia, and Kenya) [10] and Asia (specifically India [6,8,12] and Pakistan [8]).
The family Burseraceae, including the Commiphora species, are trees or shrubs with vertical resinous channels protruding from the bark. The leaves are compounded, spirally organized, and densely packed at the twig tips. Small and solitary (or in groups), the flowers grow on the branches [3] (Figure 1). Commiphora myrrha is a reddish-brown oligomycin known as one of the oldest medicines used by humanity, as it dates back to 2800 BC, according to the medical texts of ancient Egypt [13,14,15,16].
The Arabic term “Murr”, which means “Bitter”, describes the flavor and balsamic aroma of myrrh [17]. Myrrh is an aromatic resin extracted from the Commiphora tree. Historically, myrrh was extremely expensive, as it cost more than gold. The most outstanding physician in the Middle Ages, the Muslim physician Al-Razi, used the myrrh plant to treat kidney and bladder diseases and stomach bloating [12]. Its essential oils (EOs) have been used to manufacture perfumes and cosmetics and in aromatherapy as incense and for medicinal purposes for centuries [12,18,19]. Medicinally, it has been utilized as an emmenagogue, antispasmodic, antiparasitic, antitussive, and astringent. Leprosy, syphilis, and other infectious disorders, as well as cancer, have all been cured by myrrh. It is also a component of traditional medical practices in China, the Middle East, and Africa [17] and has been used since antiquity for several medicinal applications [20,21].

3. Boswellia serrata

Boswellia serrata resin, olibanum, or frankincense, is obtained from the Burseraceae family [22,23]. Boswellia is a relatively small genus with approximately 28 species [24]. Since antiquity, humans have employed medicinal plants, such as the Indian frankincense tree (Boswellia serrata), as medicines. Boswellia serrata is a medium-sized deciduous tree primarily found in India, Asia, and Africa. It has had a significant impact on curing various ailments [25,26,27] in Saudi Arabia [28], Southern Arabia, Oman [29,30,31,32], Pakistan [33], Nigeria, Yemen, and Somalia [31,34,35].
Boswellia serrata is a medium to large tree that grows up to 18 m tall and 2.4 m wide. The leaves are imparipinnate with opposing leaflets, alternating, packed at the terminals of the branches, and typically serrated. It is hermaphroditic; the flowers are tiny and white and grow in axillary racemes. Its thin, greenish-grey bark changes from yellow or red to deciduous petals that are 3–5 in number, imbricated, and eventually turn an ash color. The bark sheds in smooth, papery flakes of flaming red and secretes tiny drops of resin. After an injury or a natural break to the bark, exudate containing oleo gum resin is produced. The oleo gum resin is aromatic, clear, and golden yellow, which eventually transforms into crusts and brownish-yellow tears or drips [31,36,37,38] (Figure 2).
The therapeutic properties of Boswellia serrata have been established by numerous researchers and are well-acknowledged [38,39,40,41,42]. Its resin was recognized as one of the most significant medicinal herbs with exceptional efficacy in numerous therapeutic areas [43,44]. B. Serrata is a significant source of boswellic acid (BA) in the pharmaceutical sector. Paints and varnishes are made from high-quality turpentine from B. Serrata. However, the commercial applications of the B. Serrata oleo-primary resin are in the medication industry, western biomedicine, religious purposes, perfumes [45], and cosmetics [46]. The most significant medical applications for B. Serrata are the treatment of rheumatoid arthritis, osteoarthritis, Crohn’s disease, and asthma [38,47,48,49,50,51,52,53,54]. It is also used to treat diseases like cough and bronchitis [37,55,56,57]. It is frequently prescribed in the Unani System of Medicine for skin conditions, corneal ulcers, osteoarthritis, dysentery, chronic inflammatory illnesses, wound healing, and diarrhea [36], used as an antiobesity [58] and anticonvulsant agent [59], and is beneficial in liver fibrosis [60] and several cancers [61,62,63,64,65]. Boswellia resin is used to prevent and treat colitis and ulcerative colitis. B. Serrata shows satisfactory antioxidant activity in the cerebrovascular system [66,67] and various inflammatory conditions [68,69,70,71,72,73,74,75,76,77] and exerts antipyretic, antiatherosclerotic, and analgesic activity [38,78,79,80] in inflammatory bowel disease, allergies, and arthritis, including osteoarthritis, and pain [81,82,83,84,85]. It has also been used as an antiseptic in mouthwashes [86] and for treating chronic inflammatory diseases [87,88,89]. Its acids have been evaluated for their ability to prevent the development of periodontal biofilm [90] or the prevention of infections of the skin and nails [91,92].
Additionally, it has biological effects, including antiulcer, antiulcerogenic, antibacterial, and psychopharmacological effects [35,93,94,95,96,97,98]. Boswellia extract was used in toxicological tests on animals, and the results indicated that it was safe to use in herbal remedies [99,100]. The principal active ingredient in BA is an aromatic compound with these therapeutic effects [42,101,102]. Moreover, the US Food and Drug Administration (USFDA) has acknowledged the safety of Boswellia serrata resin and authorized its use as an ingredient in feed additives [42].
Hindus, Babylonians, Persians, Romans, Chinese, Greeks, and residents of early American civilizations have all employed natural resins, chiefly for embalming and incense at ceremonial gatherings. They had a firm conviction that when these materials were burnt, the smoke and scent they release will appease their gods and comfort their souls. Burning these organic resins had become a significant aspect of their lifestyle; they burned them during sacrifice rites and daily rituals to protect their souls from the influence of evil spirits or to honor the deceased or living [103,104,105].

4. Ingredients and Biological Activities of Myrrh and Frankincense

4.1. Main Ingredients and Compounds in Myrrh and Frankincense

Phytochemical examination of different extracts of C. Myrrha and B. Serrata reveals major active chemical components in the EO, gums, and resins. The main features and compounds of C. Myrrha and B. Serrata extracts are summarized in Table 1.

4.2. Biological Function and Activity of the Plants

4.2.1. Commiphora myrrha

Commiphora myrrha exhibits antibacterial and antifungal properties and is high in chemicals that aid treatment [12]. Its ethanolic extracts exerted antibacterial action against microorganisms to some extent [107]. Myrthanol A, a monoterpenoid alcohol from myrrh EO, has been proven to be more effective than hydrocortisone at reducing inflammation [15,16,124,125]. Several studies have established the antimicrobial activities of myrrh, including fasciolicidal, antibacterial, antiviral, and antifungal activities [126,127,128]. These inherent antibacterial and antifungal properties are due to the sesquiterpenes and furanosesquiterpenoids it contains [129,130,131]. Myrrh preparations have been classified as weakly sensitizing in local lymph node assay (LLNA) studies [21,132]. Caryophyllene C15H24, in myrrh oil, has an antibacterial, antitumor, and anti-inflammatory activity [133].

4.2.2. Boswellia serrata

B. Serrata has been reported to possess anti-inflammatory and antiarthritic activities. The anti-inflammatory activity exerts 47% inhibitory action [30,134,135,136]. The analysis of the compounds of B. Serrata extracts revealed that its triterpenoids are effective against rheumatoid arthritis, chronic colitis, ulcerative colitis, skin allergies and ulcers, tumors, osteoarthritis, and inflammation [116,137]. BAs are a mixture of pentacyclic triterpenes acids, beta-BA, 3-acetyl beta BA, 11-ketobeta-BA, and 3-acetyl-11-keto-beta-BA, which have an essential role in its anti-inflammatory activity [63,81,138]. Various studies have reported that crude extracts of the Boswellia species contain an antimicrobial agent that inhibits microbial growth [139]. Silver nanoparticles prepared from an aqueous extract of Boswellia act as an antimicrobial agent on Gram-positive and Gram-negative bacteria [140]. Other studies have also disclosed that frankincense gum resin is active against Staphylococcus aureus, Escherichia coli, Klebsiella spp., Pseudomonas aeruginosa, Proteus mirabilis, and Bacillus subtilis [141]. In addition, concentrations of α-pinene (38.41%) and myrcene (15.21%) have been reported in B. Serrata EO, whereas C. Myrrha EO was distinguished by a high furanoeudesma-1,3-diene (17.65%) content, followed by curzerene (12.97%), β-element (12.70%), and germacrene-β (12.15%), having both antimicrobial and antifungal activities [142]. The antimicrobial activity of B. Serrata extract has been demonstrated using disk diffusion or well plate and broth microdilution methods [49,90]. This activity has been investigated, and numerous therapeutic applications have revealed the pharmacological results, including many diseases, such as anti-inflammatory, antitumor, immunomodulatory, and inflammatory bowel diseases, in addition to its antioxidant activity [74,143]. Thus, it has been well established that B. Serrata possesses antibacterial and antifungal activity [44,144].

5. Cosmetic Applications of Myrrh and Frankincense

5.1. Commiphora myrrha

Commiphora myrrha is used to treat wounds, infections, acne, boils [21,145], hair, and the scalp [146,147]. It has been used to manufacture perfumes and cosmetics and used in aromatherapy [12]. The extract affected chapped and irritated skin types [148] and improved skin tone, firmness, and elasticity [149], and had a UV protection effect [150] (Figure 3).

5.2. Boswellia serrata

Frankincense EO has anti-inflammatory and antibacterial properties for all skin types, such as acne and blemish-prone skin, aging skin, and dry skin, among others, making it particularly beneficial to acne-prone skin. It alleviates oily and acne-prone skin and provides lipids for aged skin. It is also a natural toner that improves skin tone and removes pores. It is a powerful astringent and is exceedingly effective for reducing wrinkles, fine lines, scars, or stretch marks on the skin. Frankincense EO promotes new cell generation, maintains skin elasticity, and soothes dry and chapped skin [151]. It lessens or prevents the appearance of sunspots, age spots, and splotches, thus evening out the skin tone [152]. It reduces skin redness and irritation, further promoting an even skin tone [153]. It has been used as a skin remedy for bruises and infected sores [154]. It is a potent antiwrinkle and antiaging agent [155] and can be used for treating psoriasis, eczema [49,156], and skin diseases and as an antihair-loss remedy [38,50,51,53,54] (Figure 4).

6. Value-Added Cosmetic Products from C. Myrrha and B. Serrata

Since antiquity, humans have mastered the art of exploring nature to obtain vital ingredients for meeting their fundamental requirements and care for their diseases and cosmetology. Many cultures utilize natural or synthetic cosmetics to improve their skin condition and facial attractiveness. “Cosmetics” originates from the Greek term “Kosmos”, meaning to adorn, and has referred to any substance intended to enhance or beautify. The botanical ingredient of a cosmetic or personal care product is derived from plants (herbs, roots, flowers, fruits, leaves, or seeds). Many plants are employed in the cosmetics industry in many Middle Eastern countries [157]. C. Myrrha and B. Serrata have several applications in cosmetics, ranging from antiaging and soothing to anti-inflammatory, encouraging faster skin renewal and increasing skin elasticity as a skin brightener. They have been used in antiaging skincare products; both plants have hit the Western market for skincare applications. The plant extracts and oils are also used for topical applications as they confer skincare benefits. Some of the cosmetic products containing C. Myrrha and B. Serrata extracts are summarized in Table 2 and Table 3. In the following section, we will focus on the antioxidant, antiaging, and skin-whitening activities of C. Myrrha and B. Serrata.

7. Summary and Future Aspect

This review summarizes the chemical structure and biological activities of C. Myrrha and B. Serrata and their uses as cosmetic ingredients. The results of previous studies revealed their nutritional, pharmaceutical, and cosmetic benefits, as they were used over time. These plants are a natural source of medicines and cosmetics. They have anti-inflammatory, antibacterial, antioxidant, and anti-irritant properties. These plants are also antiaging, antiacne, and skin brightening and soothing. Additionally, they reduce the effects of spots and acne. It is also effective for hair and scalp health and antihair-loss.
Further developing value-added cosmetics may prevent many common skin disorders, such as eczema, chapped skin, wrinkles, dark spots, and hair loss. This review highlights the practical uses of C. Myrrha and B. Serrata as new and safe value-added products and cosmetic ingredients. Thus, using these plants for cosmetic value helps the growth of the cosmetic industry and the optimum exploitation of these natural resources.
From an economic perspective, finding natural sources with cosmetic properties and using them in the development of cosmetics helps to achieve the best use of these plants and is likely to reduce environmental losses, such as burning plants and dumping environmental waste, and helps expand the sources of income for countries exporting these plants.

Author Contributions

B.G.A. was involved in writing the original draft, and H.-J.S. provided supervision and writing revision. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Foreign Ministry of Higher Education, Technical and Vocational Training Corporation, Saudi Arabia, grant number “1442/115281 on 8/2021”.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors thank the Department of Beauty and Cosmetology, Graduate School of Industrial Technology Startup, Chosun University, 309 Pilmun-daero, Dong-gu, Gwangju 61452, Korea.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Faccio, G. Plant complexity and cosmetic innovation. IScience 2020, 23, 101358. [Google Scholar] [CrossRef] [PubMed]
  2. Ahshawat, M.S.; Saraf, S.; Saraf, S. Preparation and characterization of herbal creams for improvement of skin viscoelastic properties. Int. J. Cosmet. Sci. 2008, 30, 183–193. [Google Scholar] [CrossRef] [PubMed]
  3. Gachathi, F.N. Recent advances on classification and status of the main gum-resin producing species in the family Burseraceae. In Proceedings of the Regional Conference for Africa on Conservation, Management and utilisation of Plant gums, Resins and essential oils, Nairobi, Kenya, 6–10 October 1997. [Google Scholar]
  4. Nielsen, I.; Hedberg, I.; Edwards, S. Flora Ethiopia vol. 3, Pittosporaceae to Araliaceae. Nord. J. Bot. 1989, 12, 402. [Google Scholar] [CrossRef]
  5. Rüdiger, A.L.; Siani, A.C.; Junior, V.V. The chemistry and pharmacology of the South America genus Protium Burm. f. (Burseraceae). Pharmacogn. Rev. 2007, 1, 93–104. [Google Scholar]
  6. Shalabi, L.F.; Otaif, F.S. Commiphora Jacq (Burseraceae) in Saudi Arabia, Botanical, Phytochemical and Ethnobotanical Notes. Ecologies 2022, 3, 38–57. [Google Scholar] [CrossRef]
  7. Omer, A.S.; Mai, A.; ElAmin, E.M.; Promy, V.P.; Dagestani, M.; AlEisa, N.; AlMahasna, A. Effect of various level of dietary Commiphora myrrha on rats. Wulfenia J. 2014, 21, 1–12. [Google Scholar]
  8. Kumar, S.P.; Anjana, S.; Shukla, N.P. Phenol Free and FTA card based Genomic DNA Extraction from Stems and Leaves of Commiphora wightii and C. myrrha. J. Life Sci. 2018, 11, 25–30. [Google Scholar]
  9. Haffor, A.S.A. Effect of myrrh (Commiphora molmol) on leukocyte levels before and during healing from gastric ulcer or skin injury. J. Immunotoxicol. 2010, 7, 68–75. [Google Scholar] [CrossRef]
  10. Leminih, M.; Teketay, D. Frankincense and myrrh resources of Ethiopia: I distribution, production, opportunities for dryland development and research needs. SINET Ethiop. J. Sci. 2003, 26, 63–72. [Google Scholar] [CrossRef]
  11. Helal, E.G.; Mahmoud, A.; El-Badawy, E.E.; Kahwash, A.A. Effect of Commiphora myrrha extract on some physiological parameters and histological changes in diabetic albino rats. Egypt. J. Hosp. Med. 2005, 20, 148–162. [Google Scholar] [CrossRef]
  12. Gadir, S.A.; Ahmed, I.M. Commiphora myrrha and commiphora Africana essential oils. J. Chem. Pharm. Res. 2014, 6, 151–156. [Google Scholar]
  13. Hassanzadeh_Taheri, M.; Hosseini, M.; Dorranipour, D.; Afshar, M.; Moodi, H.; Salimi, M. The Oleo-Gum-Resin of Commiphora myrrha ameliorates male reproductive dysfunctions in streptozotocin-induced hyperglycemic rats. Pharm. Sci. 2019, 25, 294–302. [Google Scholar] [CrossRef] [Green Version]
  14. Su, S.; Hua, Y.; Wang, Y.; Gu, W.; Zhou, W.; Duan, J.A.; Tang, Y. Evaluation of the anti-inflammatory and analgesic properties of individual and combined extracts from Commiphora myrrha, and Boswellia carterii. J. Ethnopharmacol. 2012, 139, 649–656. [Google Scholar] [CrossRef]
  15. Shalaby, M.A.; Hammouda, A.A.E. Analgesic, anti-inflammatory and anti-hyperlipidemic activities of Commiphora molmol extract (Myrrh). J. Intercult. Ethnopharmacol. 2014, 3, 56. [Google Scholar] [CrossRef] [PubMed]
  16. Kavousi, A.; Nikkhah, E.; Tayarani-Najaran, Z.; Javadi, B. Wound healing effects and related mechanisms of action of methanol extracts of Boswellia sacra and Commiphora myrrha oleo-gum-resins on adult human dermal fibroblasts (HDFa). SSRN 2021, 1, 1–17. [Google Scholar] [CrossRef]
  17. Alhussaini, M.S.; Saadabi, A.M.; Alghonaim, M.I.; Ibrahim, K.E. An evaluation of the Antimicrobial activity of Commiphora myrrha Nees (Engl.) oleo-gum resins from Saudi Arabia. J. Med. Sci. 2015, 15, 198. [Google Scholar] [CrossRef] [Green Version]
  18. Lemenith, M.; Teketay, D. Frankincense and myrrh resources of Ethiopia: II. Medicinal and industrial uses. SINET Ethiop. J. Sci. 2003, 26, 161–172. [Google Scholar] [CrossRef]
  19. Tipton, D.A.; Lyle, B.; Babich, H.; Dabbous, M.K. In vitro cytotoxic and anti-inflammatory effects of myrrh oil on human gingival fibroblasts and epithelial cells. Toxicol. Vitr. 2003, 17, 301–310. [Google Scholar] [CrossRef]
  20. Madia, V.N.; De Angelis, M.; De Vita, D.; Messore, A.; De Leo, A.; Ialongo, D.; Costi, R. Investigation of Commiphora myrrha (Nees) Engl. oil and its main components for antiviral activity. Pharmaceuticals 2021, 14, 243. [Google Scholar] [CrossRef]
  21. Zhou, Q.; Liu, Y.; Tang, Y.; Shokoohinia, Y.; Chittiboyina, A.G.; Wang, M.; Avonto, C. Identification of potential skin sensitizers in myrrh. Cosmetics 2019, 6, 47. [Google Scholar] [CrossRef] [Green Version]
  22. Thulin, M.; Warfa, A.M. The frankincense trees (Boswellia spp., Burseraceae) of northern Somalia and southern Arabia. Kew Bull. 1987, 42, 487–500. [Google Scholar] [CrossRef]
  23. Hosain, N.A.; Ghosh, R.; Bryant, D.L.; Arivett, B.A.; Farone, A.L.; Kline, P.C. Isolation, structure elucidation, and immunostimulatory activity of polysaccharide fractions from Boswellia carterii frankincense resin. Int. J. Biol. Macromol. 2019, 133, 76–85. [Google Scholar] [CrossRef] [Green Version]
  24. Tolera, M.; Sass-Klaassen, U.; Eshete, A.; Bongers, F.; Sterck, F.J. Frankincense tree recruitment failed over the past half century. For. Ecol. Manag. 2013, 304, 65–72. [Google Scholar] [CrossRef]
  25. Chaurasia, A.R.T.I.; Gharia, A.N.I.L. Antifungal activity of medicinal plant Boswellia Serrata. J. Ultra Chem. 2017, 13, 88–90. [Google Scholar] [CrossRef]
  26. Hamm, S.; Bleton, J.; Connan, J.; Tchapla, A. A chemical investigation by headspace SPME and GC–MS of volatile and semi-volatile terpenes in various olibanum samples. Phytochemistry 2005, 66, 1499–1514. [Google Scholar] [CrossRef]
  27. Raja, A.F.; Ali, F.; Khan, I.A.; Shawl, A.S.; Arora, D.S. Acetyl-11-keto-β-boswellic acid (AKBA); targeting oral cavity pathogens. BMC Res. Notes 2011, 4, 406. [Google Scholar] [CrossRef] [Green Version]
  28. Kohoude, M.J.; Gbaguidi, F.; Agbani, P.; Ayedoun, M.A.; Cazaux, S.; Bouajila, J. Chemical composition and biological activities of extracts and essential oil of Boswellia dalzielii leaves. Pharm. Biol. 2017, 55, 33–42. [Google Scholar] [CrossRef] [Green Version]
  29. Shah, B.A.; Qazi, G.N.; Taneja, S.C. Boswellic acids: A group of medicinally important compounds. Nat. Prod. Rep. 2009, 26, 72–89. [Google Scholar] [CrossRef]
  30. Suchita, W.; Raman, D.M.R.; Kaur, C.D. A Review on phytochemistry and pharmacological activities of Boswellia serrata: A natural remedy. Int. J. Pharmacogn. 2021, 8, 454–461. [Google Scholar]
  31. Maupetit, P. New constituents in olibanum resinoid and essential oil. Perfum. Flavorist 1984, 9, 19–37. [Google Scholar]
  32. Leung, A.Y.; Foster, S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics; John Wiley & Sons, Inc.: New York, NY, USA, 1996. [Google Scholar]
  33. Ghorpade, R.P.; Chopra, A.; Nikam, T.D. In vitro zygotic embryo germination and propagation of an endangered Boswellia serrata Roxb., a source of boswellic acid. Physiol. Mol. Biol. Plants 2010, 16, 159–165. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Khan, I.A.; Abourashed, E.A. Leung’s encyclopedia of common natural ingredients: Used in food, drugs and cosmetics, 3rd ed.; John Wiley & Sons: Hoboken, NJ, USA, 2010. [Google Scholar]
  35. Singh, S.; Khajuria, A.; Taneja, S.C.; Khajuria, R.K.; Singh, J.; Johri, R.K.; Qazi, G.N. The gastric ulcer protective effect of boswellic acids, a leukotriene inhibitor from Boswellia serrata, in rats. Phytomedicine 2008, 15, 408–415. [Google Scholar] [CrossRef]
  36. Alam, M.; Khan, H.; Samiullah, L.; Siddique, K.M. A review on phytochemical and pharmacological studies of Kundur (Boswellia serrata Roxb ex Colebr.)-A Unani drug. J. Appl. Pharm. Sci. 2012, 2, 148–156. [Google Scholar]
  37. Ramani, P.V.; Godhani, P.J. To determine antimicrobial and phytochemical properties of Boswellia serrata leaf extracts. J. Pharmacogn. Phytochem. 2020, 9, 45–47. [Google Scholar]
  38. Siddiqui, M.Z. Boswellia serrata, a potential anti-inflammatory agent: An overview. Indian J. Pharm. Sci. 2011, 73, 255. [Google Scholar]
  39. Schrott, E.; Laufer, S.; Lammerhofer, M.; Ammon, H.P.T. Extract from gum resin of Boswellia serrata decreases [IA. sub. 2]-antibody in a patient with “Late onset Autoimmune Diabetes of the Adult” (LADA). Phytomedicine Int. J. Phytother. Phytopharm. 2014, 21, 786–787. [Google Scholar]
  40. Umar, S.; Umar, K.; Sarwar, A.H.M.G.; Khan, A.; Ahmad, N.; Ahmad, S.; Khan, H.A. Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis. Phytomedicine 2014, 21, 847–856. [Google Scholar] [CrossRef]
  41. Zhao, W.; Entschladen, F.; Liu, H.; Niggemann, B.; Fang, Q.; Zaenker, K.S.; Han, R. Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. Cancer Detect. Prev. 2003, 27, 67–75. [Google Scholar] [CrossRef]
  42. Montaser, M.M.; El-Sharnouby, M.E.; El-Noubi, G.; El-Shaer, H.M.; Khalil, A.A.; Hassanin, M.; El-Araby, D.A. Boswellia serrata resin extract in diets of Nile tilapia, Oreochromis niloticus: Effects on the growth, health, immune response, and disease resistance to Staphylococcus aureus. Animals 2021, 11, 446. [Google Scholar] [CrossRef]
  43. Hewedy, W.A. Effect of Boswellia serrata on rat trachea contractility in vitro. Nat. Prod. J. 2020, 10, 33–43. [Google Scholar] [CrossRef]
  44. Salman, K.A.; Jawad, S.M.; Abbas, S.H. Evaluation of Antibacterial Activity of Boswellia Serrata Extract Against some of the Oral Pathogenic Bacteria. Indian J. Forensic Med. Toxicol. 2021, 15, 3371. [Google Scholar]
  45. Mothana, R.A.; Hasson, S.S.; Schultze, W.; Mowitz, A.; Lindequist, U. Phytochemical composition and in vitro antimicrobial and antioxidant activities of essential oils of three endemic Soqotraen Boswellia species. Food Chem. 2011, 126, 1149–1154. [Google Scholar] [CrossRef]
  46. Gupta, M.; Verma, S.K.; Singh, S.; Trivedi, L.; Rout, P.K.; Vasudev, P.G.; Misra, L. Anti-proliferative and antibacterial activity of oleo-gum-resin of Boswellia serrata extract and its isolate 3-hydroxy-11-keto-β-boswellic acid. J. Herb. Med. 2022, 32, 100546. [Google Scholar] [CrossRef]
  47. Brendler, T.; Brinckmann, J.A.; Schippmann, U. Sustainable supply, a foundation for natural product development: The case of Indian frankincense (Boswellia serrata Roxb. ex Colebr.). J. Ethnopharmacol. 2018, 225, 279–286. [Google Scholar] [CrossRef]
  48. Majeed, M.; Prakash, L. Boswellin CG: Chemistry, Toxicology & Clinical; Sabinsa Corporation: Piscataway, NJ, USA, 2007. [Google Scholar]
  49. Mishram, S.; Bishnoi, R.S.; Maurya, R.; Jain, D. Boswellia serrata ROXB—A bioactive herbs with various pharmacological activities. Asian J. Pharm. Clin. Res. 2020, 13, 33–39. [Google Scholar] [CrossRef]
  50. Miller, A.L. Effects of Boswellia serrata on asthma. Altern. Med. Rev. 2001, 6, 20–47. [Google Scholar]
  51. Mathe, C.; Culioli, G.; Archier, P.; Vieillescazes, C. Characterization of archaeological frankincense by gas chromatography–mass spectrometry. J. Chromatogr. A 2004, 1023, 277–285. [Google Scholar] [CrossRef]
  52. Ahmed, S.; Alam, A.; Shahabuddin, M.; Khan, I.; Ali, H. Versatile pharmacological action and compound formulation of Kundur in Unani medicine: A review. Int. J. Pharmacogn. 2014, 1, 627–631. [Google Scholar]
  53. Sharma, S.; Thawani, V.; Hingorani, L.; Shrivastava, M.; Bhate, V.R.; Khiyani, R. Pharmacokinetic study of 11-keto β-Boswellic acid. Phytomedicine 2004, 11, 255–260. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Hostanska, K.; Daum, G.; Saller, R. Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro. Anticancer Res. 2002, 22, 2853–2862. [Google Scholar]
  55. Upaganlawar, A.; Ghule, B. Pharmacological activities of Boswellia serrata Roxb.—Mini review. Ethnobot. Leafl. 2009, 6, 10. [Google Scholar]
  56. Behnamrasuli, M.; Hoseinzadeh, H.; Ghafarimoghadam, G. Empowering effect of Frankincense extract on memory. Tarbiat Moalem Univ. J. Sci. 2001, 1, 1–13. [Google Scholar]
  57. Ahangarpour, A.; Heidari, H.; Fatemeh, R.A.A.; Pakmehr, M.; Shahbazian, H.; Ahmadi, I.; Mehrangiz, B.H. Effect of Boswellia serrata supplementation on blood lipid, hepatic enzymes and fructosamine levels in type2 diabetic patients. J. Diabetes Metab. Disord. 2014, 13, 29. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Zutshi, U.; Rao, P.G.; Kaur, S.; Atal, G.S.C. Mechanism of cholesterol lowering effect of Salai guggal ex-Boswellia serrata. Indian J. Pharm. 1980, 12, 59. [Google Scholar]
  59. Wildfeuer, A.; Neu, I.S.; Safayhi, H.; Metzger, G.; Wehrmann, M.; Vogel, U.; Ammon, H.P. Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis. Arzneim.-Forsch. 1998, 48, 668–674. [Google Scholar]
  60. Ahmed, H.H.; El-Alfy, N.Z.; Mahmoud, M.F.; Yahya, S.M. Boswellia serrata oleo-gum resin: A natural remedy for retrogradation of liver fibrosis in rats. Der Pharm. Lett. 2015, 7, 134–144. [Google Scholar]
  61. Liu, Z.; Liu, X.; Sang, L.; Liu, H.; Xu, Q.; Liu, Z. Boswellic acid attenuates asthma phenotypes by downregulation of GATA3 via pSTAT6 inhibition in a murine model of asthma. Int. J. Clin. Exp. Pathol. 2015, 8, 236. [Google Scholar]
  62. Houssen, M.E.; Ragab, A.; Mesbah, A.; El-Samanoudy, A.Z.; Othman, G.; Moustafa, A.F.; Badria, F.A. Natural anti-inflammatory products and leukotriene inhibitors as complementary therapy for bronchial asthma. Clin. Biochem. 2010, 43, 887–890. [Google Scholar] [CrossRef]
  63. Roy, N.K.; Parama, D.; Banik, K.; Bordoloi, D.; Devi, A.K.; Thakur, K.K.; Kunnumakkara, A.B. An update on pharmacological potential of boswellic acids against chronic diseases. Int. J. Mol. Sci. 2019, 20, 4101. [Google Scholar] [CrossRef] [Green Version]
  64. Suther, C.; Daddi, L.; Bokoliya, S.; Panier, H.; Liu, Z.; Lin, Q.; Zhou, Y. Dietary Boswellia serrata Acid Alters the Gut Microbiome and Blood Metabolites in Experimental Models. Nutrients 2022, 14, 814. [Google Scholar] [CrossRef]
  65. Ranjbarnejad, T.; Saidijam, M.; Moradkhani, S.; Najafi, R. Methanolic extract of Boswellia serrata exhibits anti-cancer activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells. Prostaglandins Other Lipid Mediat. 2017, 131, 1–8. [Google Scholar] [CrossRef] [PubMed]
  66. Assimopoulou, A.N.; Zlatanos, S.N.; Papageorgiou, V.P. Antioxidant activity of natural resins and bioactive triterpenes in oil substrates. Food Chem. 2005, 92, 721–727. [Google Scholar] [CrossRef]
  67. Yassin, N.A.Z.; El-Shenawy, S.M.A.; Mahdy, K.A.; Gouda, N.A.M.; Marrie, A.E.-F.H.; Farrag, A.R.H.; Ibrahim, B.M.M. Effect of Boswellia serrata on Alzheimer’s disease induced in rats. J. Arab Soc. Med. Res. 2013, 8, 1–11. [Google Scholar]
  68. Gupta, I.; Gupta, V.; Parihar, A.; Gupta, S.; Lüdtke, R.; Safayhi, H.; Ammon, H.P. Effects of Boswellia serrata gum resin in patients with bronchial asthma: Results of a double-blind, placebo-controlled, 6-week clinical study. Eur. J. Med. Res. 1998, 3, 511–514. [Google Scholar] [PubMed]
  69. Ammon, H.P.T. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006, 72, 1100–1116. [Google Scholar] [CrossRef] [Green Version]
  70. Abdel-Tawab, M.; Werz, O.; Schubert-Zsilavecz, M. Boswellia serrata. Clin. Pharmacokinet. 2011, 50, 349–369. [Google Scholar] [CrossRef]
  71. Pop, R.M.; Popolo, A.; Trifa, A.P.; Stanciu, L.A. Phytochemicals in cardiovascular and respiratory diseases: Evidence in oxidative stress and inflammation. Oxidative Med. Cell. Longev. 2018, 2018, 1603872. [Google Scholar] [CrossRef]
  72. Etzel, R. Special extract of Boswellia serrata (H 15) in the treatment of rheumatoid arthritis. Phytomedicine 1996, 3, 91–94. [Google Scholar] [CrossRef]
  73. Roy, S.; Khanna, S.; Shah, H.; Rink, C.; Phillips, C.; Preuss, H.; Sen, C.K. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol. 2005, 24, 244–255. [Google Scholar] [CrossRef]
  74. Alluri, V.K.; Kundimi, S.; Sengupta, K.; Golakoti, T.; Kilari, E.K. An anti-inflammatory composition of Boswellia serrata resin extracts alleviates pain and protects cartilage in monoiodoacetate-induced osteoarthritis in rats. Evid.-Based Complement. Altern. Med. 2020, 2020, 7381625. [Google Scholar] [CrossRef]
  75. Engels, G. Frankincense, herbal gram. J. Am. Bot. Coun. 2010, 88, 1–4. [Google Scholar]
  76. Kuo, R.Y.; Qian, K.; Morris-Natschke, S.L.; Lee, K.H. Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents. Nat. Prod. Rep. 2009, 26, 1321–1344. [Google Scholar] [CrossRef]
  77. Asante-Kwatia, E.; Yeboah Mensah, A.; Frimpong Baidoo, M. Analgesic and anti-inflammatory effect of ghanaian medicinal plants. In Medicinal Plants-Use in Prevention and Treatment of Diseases, 2nd ed.; Bassam, A.R.H., Ed.; IntechOpen: London, UK, 2020; Volume 3, p. 192. [Google Scholar]
  78. Pirotta, M. Arthritis disease: The use of complementary therapies. Aust. Fam. Physician 2020, 39, 638–640. [Google Scholar]
  79. Singh, G.B.; Atal, C.K. Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions 1986, 18, 407–412. [Google Scholar] [CrossRef] [PubMed]
  80. Kumar, R.; Singh, S.; Saksena, A.K.; Pal, R.; Jaiswal, R.; Kumar, R. Effect of Boswellia serrata extract on acute inflammatory parameters and tumor necrosis factor-α in complete Freund’s adjuvant-induced animal model of rheumatoid arthritis. Int. J. Appl. Basic Med. Res. 2019, 9, 100. [Google Scholar] [CrossRef]
  81. Iram, F.; Khan, S.A.; Husain, A. Phytochemistry and potential therapeutic actions of Boswellic acids: A mini review. Asian Pac. J. Trop. Biomed. 2017, 7, 513–523. [Google Scholar] [CrossRef]
  82. Vishal, A.A.; Mishra, A.; Raychaudhuri, S.P. A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of Aflapin® in subjects with osteoarthritis of knee. Int. J. Med. Sci. 2011, 8, 615. [Google Scholar] [CrossRef] [Green Version]
  83. Sengupta, K.; Alluri, K.V.; Satish, A.R.; Mishra, S.; Golakoti, T.; Sarma, K.V.; Raychaudhuri, S.P. A double blind, randomized, placebo-controlled study of the efficacy and safety of 5-Loxin® for treatment of osteoarthritis of the knee. Arthritis Res. Ther. 2008, 10, R85. [Google Scholar] [CrossRef] [Green Version]
  84. Sengupta, K.; Krishnaraju, A.V.; Vishal, A.A.; Mishra, A.; Trimurtulu, G.; Sarma, K.V.; Raychaudhuri, S.P. Comparative efficacy and tolerability of 5-Loxin® and Aflapin® against osteoarthritis of the knee: A double blind, randomized, placebo controlled clinical study. Int. J. Med. Sci. 2010, 7, 366. [Google Scholar] [CrossRef] [Green Version]
  85. Kulkarni, R.R.; Patki, P.S.; Jog, V.P.; Gandage, S.G.; Patwardhan, B. Treatment of osteoarthritis with a herbomineral formulation: A double-blind, placebo-controlled, cross-over study. J. Ethnopharmacol. 1991, 33, 91–95. [Google Scholar] [CrossRef]
  86. Ali, N.A.A.; Wurster, M.; Arnold, N.; Teichert, A.; Schmidt, J.; Lindequist, U.; Wessjohann, L. Chemical composition and biological activities of essential oils from the oleogum resins of three endemic Soqotraen Boswellia species. Rec. Nat. Prod. 2008, 2, 6. [Google Scholar]
  87. Ammon, H.P.T. Boswellic acids and their role in chronic inflammatory diseases. Anti-Inflamm. Nutraceuticals Chronic Dis. 2016, 928, 291–327. [Google Scholar]
  88. Ernst, E. Frankincense: Systematic review. BMJ 2008, 337, a2813. [Google Scholar] [CrossRef] [Green Version]
  89. Majeed, M.; Majeed, S.; Narayanan, N.K.; Nagabhushanam, K. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytother. Res. 2019, 33, 1457–1468. [Google Scholar] [CrossRef] [Green Version]
  90. Vahabi, S.; Hakemi-Vala, M.; Gholami, S. In vitro antibacterial effect of hydroalcoholic extract of Lawsonia inermis, Malva sylvestris, and Boswellia serrata on aggregatibacter actinomycetemcomitans. Adv. Biomed. Res. 2019, 8, 22. [Google Scholar] [CrossRef]
  91. Sadhasivam, S.; Palanivel, S.; Ghosh, S. Synergistic antimicrobial activity of Boswellia serrata Roxb. ex Colebr.(Burseraceae) essential oil with various azoles against pathogens associated with skin, scalp and nail infections. Lett. Appl. Microbiol. 2016, 63, 495–501. [Google Scholar] [CrossRef]
  92. Jaroš, P.; Vrublevskaya, M.; Lokočová, K.; Michailidu, J.; Kolouchová, I.; Demnerová, K. Boswellia serrata Extract as an Antibiofilm Agent against Candida spp. Microorganisms 2022, 10, 171. [Google Scholar] [CrossRef] [PubMed]
  93. Menon, M.K.; Kar, A. Analgesic and psychopharmacological effects of the gum resin of Boswellia serrata. Planta Med. 1971, 19, 333–341. [Google Scholar] [CrossRef] [PubMed]
  94. Gupta, M.; Rout, P.K.; Misra, L.N.; Gupta, P.; Singh, N.; Darokar, M.P.; Bhakuni, R.S. Chemical composition and bioactivity of Boswellia serrata Roxb. essential oil in relation to geographical variation. Plant Biosyst.-Int. J. Deal. All Asp. Plant Biol. 2017, 151, 623–629. [Google Scholar]
  95. Khan, M.A.; Singh, M.; Khan, M.S.; Najmi, A.K.; Ahmad, S. Caspase mediated synergistic effect of Boswellia serrata extract in combination with doxorubicin against human hepatocellular carcinoma. Biomed Res. Int. 2014, 2014, 294143. [Google Scholar] [CrossRef] [Green Version]
  96. Ayub, M.A.; Hanif, M.A.; Sarfraz, R.A.; Shahid, M. Biological activity of Boswellia serrata Roxb. oleo gum resin essential oil: Effects of extraction by supercritical carbon dioxide and traditional methods. Int. J. Food Prop. 2018, 21, 808–820. [Google Scholar] [CrossRef] [Green Version]
  97. Van Vuuren, S.F. Antimicrobial activity of South African medicinal plants. J. Ethnopharmacol. 2008, 119, 462–472. [Google Scholar] [CrossRef] [PubMed]
  98. Gaurea, S.H.; Bapat, U.C. Study of antibacterial activity of resins of Boswellia serrata roxb ex colebr., Commiphora mukul (hooks ex-stocks) engl., Gardenia resinifera roth. And Shorea robusta gaertn. Int. J. Pharm. Pharm. Sci. 2016, 8, 29–31. [Google Scholar]
  99. Lalithakumari, K.; Krishnaraju, A.V.; Sengupta, K.; Subbaraju, G.V.; Chatterjee, A. Safety and toxicological evaluation of a novel, standardized 3-O-acetyl-11-keto-β-boswellic acid (AKBA)-enriched Boswellia serrata extract (5-Loxin®). Toxicol. Mech. Methods 2006, 16, 199–226. [Google Scholar] [CrossRef]
  100. Katragunta, K.; Siva, B.; Kondepudi, N.; Vadaparthi, P.R.; Rao, N.R.; Tiwari, A.K.; Babu, K.S. Estimation of boswellic acids in herbal formulations containing Boswellia serrata extract and comprehensive characterization of secondary metabolites using UPLC-Q-Tof-MSe. J. Pharm. Anal. 2019, 9, 414–422. [Google Scholar] [CrossRef] [PubMed]
  101. Camarda, L.; Dayton, T.; Di Stefano, V.; Pitonzo, R.; Schillaci, D. Chemical composition and antimicrobial activity of some oleogum resin essential oils from Boswellia spp. (Burseraceae). Ann. Di Chim. J. Anal. Environ. Cult. Herit. Chem. 2007, 97, 837–844. [Google Scholar]
  102. Mannino, G.; Occhipinti, A.; Maffei, M.E. Quantitative determination of 3-O-acetyl-11-keto-β-boswellic acid (AKBA) and other boswellic acids in Boswellia sacra Flueck (syn. B. carteri Birdw) and Boswellia serrata Roxb. Molecules 2016, 21, 1329. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Murthy, T.K.; Shiva, M.P. Salai guggul from Boswellia serrata Roxb.—Its exploitation and utilization. Indian For. 1977, 103, 466–474. [Google Scholar]
  104. Verghese, J. Olibanum in focus. Perfum. Flavorist 1988, 13, 1–12. [Google Scholar]
  105. Holmes, P. Frankincense oil. Int. J. Arom. 1999, 9, 56–61. [Google Scholar]
  106. Evans, W.C. A taxonomic approach to the study of medicinal plants and animal derived drugs. Trease and Evans Pharmacognosy. WB Saunders 2002, 15, 33–35. [Google Scholar]
  107. Chandrasekharnath, N.; Mahlakshmi, Y.V.; Jayalakshmi, L.; Venkanna, B.; Uma, A. Screening and isolation of bioactive factors from Commiphora myrrha and evaluation of their antimicrobial activity. IJERA 2013, 3, 1291–1294. [Google Scholar]
  108. Suliman, R.S.; Alghamdi, S.S.; Ali, R.; Aljatli, D.; Aljammaz, N.A.; Huwaizi, S.; Rahman, I. The Role of Myrrh Metabolites in Cancer, Inflammation, and Wound Healing: Prospects for a Multi-Targeted Drug Therapy. Pharmaceuticals 2022, 15, 944. [Google Scholar] [CrossRef] [PubMed]
  109. Su, S.; Duan, J.; Chen, T.; Huang, X.; Shang, E.; Yu, L.; Tang, Y. Frankincense and myrrh suppress inflammation via regulation of the metabolic profiling and the MAPK signaling pathway. Sci. Rep. 2015, 5, 13668. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  110. Su, S.; Wang, T.; Duan, J.A.; Zhou, W.; Hua, Y.Q.; Tang, Y.P.; Qian, D.W. Anti-inflammatory and analgesic activity of different extracts of Commiphora myrrha. J. Ethnopharmacol. 2011, 134, 251–258. [Google Scholar] [CrossRef]
  111. Fatani, A.J.; Alrojayee, F.S.; Parmar, M.Y.; Abuohashish, H.M.; Ahmed, M.M.; Al-Rejaie, S.S. Myrrh attenuates oxidative and inflammatory processes in acetic acid-induced ulcerative colitis. Exp. Ther. Med. 2016, 12, 730–738. [Google Scholar] [CrossRef] [Green Version]
  112. Abukhader, R.; Al tawaha, A. Amazing Benefits of Myrrh. Int. J. Pharm. Res. 2021, 13, 303–308. [Google Scholar]
  113. Rastogi Ram, P.; Mehrotra, B.N. Compendium of Indian medicinal plants. New Delhi Lucknow NISCAIR 1993, 4, 1. [Google Scholar]
  114. Rastogi, R.P.; Mehrotra, B.N. Compendium of Indian Medicinal Plants; Central Drug Research Institute: Lucknow, India, 1990; Volume 4. [Google Scholar]
  115. Al-Harrasi, A.; Al-Saidi, S. Phytochemical analysis of the essential oil from botanically certified oleogum resin of Boswellia sacra (Omani Luban). Molecules 2008, 13, 2181–2189. [Google Scholar] [CrossRef] [Green Version]
  116. Rashan, L.; Hakkim, F.L.; Idrees, M.; Essa, M.; Velusamy, T.; Al-Baloshi, M.; Hasson, S.S. Boswellia gum resin and essential oils: Potential health benefits—An evidence based review. Int. J. Nutr. Pharmacol. Neurol. Dis. 2019, 9, 53–71. [Google Scholar] [CrossRef]
  117. Al-Yasiry, A.R.M.; Kiczorowska, B. Frankincense-therapeutic properties. Adv. Hyg. Exp. Med./Postep. Hig. I Med. Dosw. 2016, 70, 380–391. [Google Scholar] [CrossRef] [PubMed]
  118. Niebler, J.; Buettner, A. Identification of odorants in frankincense (Boswellia sacra Flueck.) by aroma extract dilution analysis and two-dimensional gas chromatography–mass spectrometry/olfactometry. Phytochemistry 2015, 109, 66–75. [Google Scholar] [CrossRef] [PubMed]
  119. Al-Harrasi, A.; Csuk, R.; Khan, A.; Hussain, J. Distribution of the anti-inflammatory and anti-depressant compounds: Incensole and incensole acetate in genus Boswellia. Phytochemistry 2019, 161, 28–40. [Google Scholar] [CrossRef] [PubMed]
  120. Herrmann, A.; Lechtenberg, M.; Hensel, A. Comparative isolation and structural investigations of polysaccharides from Boswellia serrata ROXB. and Boswellia carteri BIRDW. Planta Med. 2007, 73, 09. [Google Scholar] [CrossRef]
  121. Sharma, R.A.; Varma, K.C. Studies on gum obtained from Boswellia serrata Roxb. Indian Drugs 1980, 17, 225–227. [Google Scholar]
  122. Bhuchar, V.M.; Agrawal, A.; Sharma, S.K. Constituents of the gum obtained from Boswalia-serrata exudate. Indian J. Technol. 1982, 20, 38–40. [Google Scholar]
  123. Gangwal, M.L.; Vardhan, D.K. Carbohydrate contents of Boswellia serrata. Asian J. Chem. 1995, 7, 677. [Google Scholar]
  124. Hana, D.B.; Kadhim, H.M.; Jasim, G.A.; Latif, Q.N. Antibacterial activity of Commiphora molmol extracts on some bacterial species in Iraq. Sch. Acad. J. Pharm. 2016, 5, 406–412. [Google Scholar]
  125. Maver, T.; Maver, U.; Stana Kleinschek, K.; Smrke, D.M.; Kreft, S. A review of herbal medicines in wound healing. Int. J. Dermatol. 2015, 54, 740–751. [Google Scholar] [CrossRef]
  126. Massoud, A.; El Sisi, S.A.W.S.A.N.; Salama, O. Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh). Am. J. Trop. Med. Hyg. 2001, 65, 96–99. [Google Scholar] [CrossRef] [Green Version]
  127. Buckley, S.A.; Evershed, R.P. Organic chemistry of embalming agents in Pharaonic and Graeco-Roman mummies. Nature 2001, 413, 837–841. [Google Scholar] [CrossRef] [PubMed]
  128. Cenci, E.; Messina, F.; Rossi, E.; Epifano, F.; Marcotullio, M.C. Antiviral furanosesquiterpenes from Commiphora erythraea. Nat. Prod. Commun. 2012, 7, 143–144. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  129. Mohamed, A.G.; Abbas, H.M.; Kassem, J.M.; Gafour, W.A.; Attalah, A.G. Impact of myrrh essential oil as a highly effective antimicrobial agent in processed cheese spreads. Int. J. Dairy Sci. 2016, 11, 41–51. [Google Scholar] [CrossRef] [Green Version]
  130. Marcotullio, M.C.; Rosati, O.; Lanari, D. Phytochemistry of Commiphora erythraea: A Review. Nat. Prod. Commun. 2018, 13, 1209–1212. [Google Scholar] [CrossRef] [Green Version]
  131. Ajiteru, O.; Lee, O.J.; Kim, J.H.; Lee, Y.J.; Lee, J.S.; Lee, H.; Park, C.H. Fabrication and characterization of a myrrh hydrocolloid dressing for dermal wound healing. Colloid Interface Sci. Commun. 2022, 48, 100617. [Google Scholar] [CrossRef]
  132. Lv, L.; Yan, G.Y.; Zhao, Y.L.; He, X.J.; Jiang, X.; Zhuo, Y.Q.; Cen, X.B. Investigation of the dermal sensitizing potential of traditional medical extracts in local lymph node assays. Exp. Biol. Med. 2009, 234, 306–313. [Google Scholar] [CrossRef] [PubMed]
  133. Kamil, N.B.; Al-Ghaban, N.M. Evaluation the effects of local exogenous application of a mixture of Myrrh and Sage oil on incisional wound healing on the skin of the face (Histological, Histochemical and Histomorphpmetrical study in rabbits). J. Pharm. Sci. Res. 2018, 10, 1030–1035. [Google Scholar]
  134. Atal, C.K.; Singh, G.B.; Batra, S.; Sharma, S.; Gupta, O.P. Salai Guggal ex-Boswellia serrata a promising anti-hyperlipidemic and anti-arthritic agent. Indian J. Exp. Biol. 1980, 12, 59. [Google Scholar]
  135. Atal, C.K.; Gupta, O.P.; Singh, G.B. Salai-guggal a promising anti-arthritic and anti-hyperlipidemic agent. Br. J. Pharmacol. 1981, 74, 203–204. [Google Scholar]
  136. Ammon, H.P.T.; Safayhi, H.; Mack, T.; Sabieraj, J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J. Ethnopharmacol. 1993, 38, 105–112. [Google Scholar] [CrossRef]
  137. Hussain, H.; Al-Harrasi, A.; Csuk, R.; Shamraiz, U.; Green, I.R.; Ahmed, I.; Ali, Z. Therapeutic potential of boswellic acids: A patent review (1990-2015). Expert Opin. Ther. Pat. 2017, 27, 81–90. [Google Scholar] [CrossRef] [PubMed]
  138. Hajhashemi, V.; Safaei, S. Effect of a selection of skin penetration enhancers on topical anti-inflammatory effect of Boswellic acids in carrageenan-induced paw edema in rats. Adv. Biomed. Res. 2021, 10, 18. [Google Scholar] [CrossRef] [PubMed]
  139. Haghaei, H.; Soltani, S.; Hosseini, S.A.; Rashidi, M.R.; Karima, S. Boswellic acids as promising leads in drug development against Alzheimer’s disease. Pharm. Sci. 2020, 27, 14–31. [Google Scholar] [CrossRef]
  140. Kora, A.J.; Sashidhar, R.B.; Arunachalam, J. Aqueous extract of gum olibanum (Boswellia serrata): A reductant and stabilizer for the biosynthesis of antibacterial silver nanoparticles. Process Biochem. 2021, 47, 1516–1520. [Google Scholar] [CrossRef]
  141. Ismail, S.M.; Aluru, S.; Sambasivarao, K.R.S.; Matcha, B. Antimicrobial activity of frankincense of Boswellia serrata. Int. J. Curr. Microbiol. App. Sci. 2014, 3, 1095–1101. [Google Scholar]
  142. De Rapper, S.; Van Vuuren, S.F.; Kamatou, G.P.P.; Viljoen, A.M.; Dagne, E. The additive and synergistic antimicrobial effects of select frankincense and myrrh oils—A combination from the pharaonic pharmacopoeia. Lett. Appl. Microbiol. 2012, 54, 352–358. [Google Scholar] [CrossRef]
  143. Alluri, V.K.; Dodda, S.; Kilari, E.K.; Golakoti, T.; Sengupta, K. Toxicological assessment of a standardized Boswellia serrata gum resin extract. Int. J. Toxicol. 2019, 38, 423–435. [Google Scholar] [CrossRef]
  144. Di Stefano, V.; Schillaci, D.; Cusimano, M.G.; Rishan, M.; Rashan, L. In vitro antimicrobial activity of frankincense oils from Boswellia sacra grown in different locations of the Dhofar region (Oman). Antibiotics 2020, 9, 195. [Google Scholar] [CrossRef] [Green Version]
  145. Grbić, M.L.; Unković, N.; Dimkić, I.; Janaćković, P.; Gavrilović, M.; Stanojević, O.; Vukojević, J. Frankincense and myrrh essential oils and burn incense fume against micro-inhabitants of sacral ambients. Wisdom of the ancients? J. Ethnopharmacol. 2018, 219, 1–14. [Google Scholar] [CrossRef]
  146. El Ashry, E.S.H.; Rashed, N.; Salama, O.M.; Saleh, A. Components, therapeutic value and uses of myrrh. Die Pharm.-Int. J. Pharm. Sci. 2003, 58, 163–168. [Google Scholar]
  147. Shameem, I. Phytochemical & therapeutic potentials of Murr makki (Commiphora myrrha): A review. Indian J. Appl. Res. 2018, 8, 102–104. [Google Scholar]
  148. Ashry, K.M.; El-Sayed, Y.S.; Khamiss, R.M.; El-Ashmawy, I.M. Oxidative stress and immunotoxic effects of lead and their amelioration with myrrh (Commiphora molmol) emulsion. Food Chem. Toxicol. 2010, 48, 236–241. [Google Scholar] [CrossRef] [PubMed]
  149. Happy, A.A.; Jahan, F.; Momen, M.A. Essential Oils: Magical Ingredients for Skin Care. J. Plant Sci. 2021, 9, 54–64. [Google Scholar]
  150. Chakravarty, N.; Kellogg, C.; Alvarez, J.; Equils, O.; Morgan, M. UV Protection by Natural Products: C. myrrha Oil Versus Sunscreen. J. Drugs Dermatol. 2018, 17, 905–907. [Google Scholar]
  151. Hamidpour, R.; Hamidpour, S.; Hamidpour, M.; Shahlari, M. Frankincense (乳香 Rǔ Xiāng; Boswellia species): From the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases. J. Tradit. Complement. Med. 2013, 3, 221–226. [Google Scholar] [CrossRef] [Green Version]
  152. Mikhaeil, B.R.; Maatooq, G.T.; Badria, F.A.; Amer, M.M. Chemistry and immunomodulatory activity of frankincense oil. Z. Nat. C 2003, 58, 230–238. [Google Scholar] [CrossRef]
  153. Eyre, H.; Hills, M.J.; Watkins, S.D. Compositions containing Boswellia extracts. Quest Int. BV 2003, 6, 516. [Google Scholar]
  154. Michie, C.A.; Cooper, E. Frankincense and myrrh as remedies in children. J. R. Soc. Med. 1991, 84, 602. [Google Scholar] [CrossRef]
  155. Kaur, A.; Singh, T.G.; Dhiman, S.; Arora, S.; Babbar, R. Novel herbs used in cosmetics for skin and hair care: A. review. Plant Arch. 2020, 20, 3784–3793. [Google Scholar]
  156. Togni, S.; Maramaldi, G.; Di Pierro, F.; Biondi, M. A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis. Clin. Cosmet. Investig. Dermatol. 2014, 7, 321. [Google Scholar]
  157. Sawicka, B.; Noaema, A. Cosmetics active ingredients used in the Middle East. In Proceedings of the II National Scientific Conference “Modern Technologies and Treatments in Cosmetology”, Tomsk, Russia, 29–30 September 2015. [Google Scholar]
Figure 1. (a) Commiphora myrrha tree; (b) resin appears from the tree trunk; (c) C. Myrrha resin; (d) illustration of C. Myrrha plant. All pictures and illustrations do not have any copyright issues.
Figure 1. (a) Commiphora myrrha tree; (b) resin appears from the tree trunk; (c) C. Myrrha resin; (d) illustration of C. Myrrha plant. All pictures and illustrations do not have any copyright issues.
Cosmetics 09 00119 g001
Figure 2. (a) Boswellia serrata tree; (b) resin appears from the tree trunk; (c) B. Serrata resin; (d) Illustration of B. Serrata plant. All pictures and illustrations do not have any copyright issues.
Figure 2. (a) Boswellia serrata tree; (b) resin appears from the tree trunk; (c) B. Serrata resin; (d) Illustration of B. Serrata plant. All pictures and illustrations do not have any copyright issues.
Cosmetics 09 00119 g002
Figure 3. The illustrated summary of the cosmetic uses of C. Myrrha.
Figure 3. The illustrated summary of the cosmetic uses of C. Myrrha.
Cosmetics 09 00119 g003
Figure 4. The illustrated summary of the cosmetic uses of B. Serrata.
Figure 4. The illustrated summary of the cosmetic uses of B. Serrata.
Cosmetics 09 00119 g004
Table 1. Main ingredients and compounds in Commiphora myrrha and Boswellia serrata.
Table 1. Main ingredients and compounds in Commiphora myrrha and Boswellia serrata.
Commiphora myrrha:References
Water-soluble gum, alcohol-soluble resins, polysaccharides, and proteins; steroids, sterols, and terpenes make up the volatile oil; and furanosesquiterpenes.[106]
3–8% essential oil, 30–60% water-soluble gum, and 25–40% alcohol-soluble resin.[16]
Flavonoids, alkaloids, tannins, glycosides, steroids, saponins, and terpenoids. The methanolic extract is high in bioactive components, such as flavonoids and glycosides.[107]
Myrrin, sesquiterpenes, aldehyde, eugenols, and protein.[7]
α-, β- and γ-commiphoric acid; α- and β-heerabomyrrhol; protocatechuic acid, and pyrocathechin[108]
2-Methoxy-5acetoxyfruranogermacr-1(10)-en-6-one and abietic acid.[109,110,111]
Diterpenic acids, sesquiterpenes, 2-Methoxy-8,12-epoxygermacra-1(10) 7,11-trine-6-one, myrrhone, sandaracopimaric acid, abietic acid, dehydroabietic acid, and mansumbinone[112]
Boswellia serrata:
Arabinose, rhamnose, glucose, galactose, fructose, galacturonic acid, and β sitosterol; phenol-o-cresol, m-cresol, p-cresol, thymol, and carvacrol; carboxylic acid-α-campholenic acid 2,2,4-trimethylcyclopent-3-en-1-yl acetic acid, and campholytic acid.[113,114]
Portion (97.3%) in E-β-ocimene and limonene, (2.7%) sesquiterpenes, in E-caryophyllene.[115]
Resin acids (60–70%), water-soluble gum (about 20%), and monoterpene essential oil (3–10%)[116]
Oil (45%), α-thujene (12%), α-pinene (8%), sabinene (2.2%), β-pinene (0.7%), myrcene (3.8%), α-phellandrene (1%), pcymene (1%), limonene (1.9%), linalool (0.9%), perillene (0.5%), methylchavicol (11.6%), methyleugenol (2.1%), germacrene D (2.0%), kessane (0.9%), cembrene A (0.5%), and cembrenol (1.9%); a monoterpene 5,5-dimethyl-1-vinylbicyclo- hexane (2%), m-camphorene (0.7%); and p-camphorene (0.3%)[117]
Diterpenes, cembrenol (serratol), incensole, and incensole acetate[118,119]
Lipophilic pentacyclic triterpene acids of the oleanane (α-BAs), ursane-(β-BAs) and lupane-type (lupeolic acids), and an ether-insoluble fraction polysaccharide (arabinose, galactose, xylose) soluble in water[38,120,121,122,123]
Table 2. Cosmetic products containing C. Myrrha.
Table 2. Cosmetic products containing C. Myrrha.
Product NameC. Myrrha/Extract IncludedFunction
Complexion Polish—Natural Face Exfoliant, Sydney, AustraliaResin ExtractThis technique helps to purify the skin and remove toxins. It is highly effective on mature skin because it helps in cell renewal
Knight Co.—Repairing Face Oil, Los Angeles, USAResin ExtractAntiaging.
Hey honey—911 PRO GEL, Sarasota, Florida, USAResin ExtractSoothe and correct acne, inflammation, and scarring.
Beb organic—Soothing Serum, Simi Valley, California, USAResin ExtractTreat spots from acne and damaged skin.
SheaMoisture—Raw shea butter face & body bar soap, Amityville, New York, USAFrankincense and Myrrh ExtractGlowing skin.
Hey honey—Don’t miss a spot, Sarasota, Florida, USAResin ExtractNatural antiseptic, astringent, and disinfectant.
Biologique Recherche—Gommage P50 Corps, Paris, FranceResin ExtractReplenishes the epidermis, antioxidant.
Biologique Recherche—Masque Gommage Mains, Paris, FranceResin ExtractTreatment of pigmentation.
Biology Recherche—Lotion P50, Paris, FranceResin ExtractBrightening.
Biologique Recherche—Creme Grand Millesime, Paris, FranceResin ExtractAntioxidant.
Biologique Recherche—Serum Renovateur 14, Paris, FranceResin ExtractAntioxidant.
SheaMoisture—Raw Shea Butter Hydrating Moisturizer W/Frankincense & Myrrh Amityville, New York, USAResin ExtractAnti-inflammatory, antibacterial and antiaging properties.
Biologique Recherche—Le Grand Serum, Paris, FranceResin ExtractAntiaging.
Bliss—Pore Patrol Oil Free Hydrator With Willow Bark, New York, USAResin ExtractAntimicrobial and antibacterial.
Biologique Recherche—Masque Creme Biofixine, Paris, FranceResin ExtractAntiwrinkle and muscle-relaxing.
Sunday 2 Sunday—Root Refresh Micellar Rinse, Airtech Pkwy, Plainfield, USAResin ExtractCleans the hair and scalp.
Colleen Rothschild Beauty—Restorative Hand Cream, Texas, USAResin ExtractSoothes the skin.
Kiss the Moon—Glow Night-Time Face Oil, Richmond, UKResin ExtractHelps glow, nourish, and restore dehydrated skin.
Country Comfort—Herbal Savvy Goldenseal Myrrh, Nuevo, California, USAMyrrh gum powderDisinfecting ointment for psoriasis, eczema, burns, infections, cuts, wounds, scrapes, and dry skin.
Jean D’Arcel—Anti Wrinkle Lift Stick, Melbourne, Australia Resin ExtractAntimicrobial/antibacterial.
Anne Semonin—Super Active Serum, Paris, FranceResin ExtractReduces the depth of wrinkles and skin plumping.
Kuwait shop—Myrrh And Turmeric Lightening And Clarifying Cream, Kuwait, KuwaitResin ExtractContributes to the unification and natural lightening of the skin tone.
Lush—Beauty Sleep, Vancouver, CanadaResin ExtractAntimicrobial and antibacterial.
Table 3. Cosmetic products containing B. Serrata.
Table 3. Cosmetic products containing B. Serrata.
Product NameB. Serrata/Extract IncludedFunction
Formula Dra Norma Bustos—Anti Stress Dérmico, Buenos Aires, ArgentinaB. Serrata ExtractSoothes skin.
Bioearth—Siero Idratante Lenitivo, Fornovo di Taro, ItalyB. Serrata ExtractSoothes skin.
Smooth-E—Acne Treatment Hydrogel, Bangkok, ThailandB. Serrata ExtractRelieve inflammation of acne, treat acne, and gently soothes the skin.
Cantabria Labs Biretix—Gel Ultra Purifying, Madrid, SpainB. Serrata ExtractHydrating and soothing activity.
Dermedics—YOUTH EXPERT™ Instant Relief Eye Serum, Selangor, MalaysiaB. Serrata ExtractAnti-irritant.
Dermedics—MESO CALM Instant Soothing Elixir, Selangor, MalaysiaB. Serrata ExtractSoothes irritations.
Dermedics—YOUTH EXPERT™ Physiological Micellar Water, Selangor, MalaysiaB. Serrata ExtractAnti-irritant.
Ossola Skincare—Prickly Pear & Marula Tinted Emulsion, Carmel-By-The-Sea, California, USAB. Serrata ExtractSoothes skin.
Aveda—outer peace™ acne relief pads, New York, USAB. Serrata ExtractHelp wipe out blackheads and prevent new breakouts.
I image—CLEAR CELL clarifying salicylic tonic, Lantana, Florida, USAB. Serrata ExtractRefresh and purify clogged pores and help soothe irritated skin.
Aveda—men pure-formance™ conditioner, New York, USAB. Serrata ExtractRefreshes scalp.
Dermadoctor—Ain’T Misbehavin’ Intensive 10% Sulfur Acne Mask & Emergency Spot Treatment, Kansas, USAB. Serrata ExtractHelps reduce the appearance of spots and blackheads. It also helps the skin to recover
Dermalex—Rosacea Treatment, London, UKB. Serrata ExtractRelieve different skin conditions.
NPURE—Day Cream Centella, Jakarta, IndonesiaB. Serrata ExtractAntiacne.
Flexpower—Soothe Lotion, Santa Monica, California, USAB. Serrata ExtractSoothes, anti-inflammatory.
Found—Marshmallow Calming Face Serum, Los Angeles, USAB. Serrata ExtractSkin conditioning.
Ausceuticals—Collagen Serum, Perth, AustraliaB. Serrata ExtractSkin conditioning.
Aveda—Outer Peace™ Foaming Cleanser, New York, USAB. Serrata ExtractCleans deep into pores without irritation or over-drying skin.
Biodermal—Couperose Crème, Rotterdam, NetherlandsB. Serrata ExtractSoothes skin.
ITreatSkin—Neem Cream, Manchester, UKB. Serrata ExtractSoothes and reduces skin Inflammation.
Kate Ryan—Collagen Booster Intense Repair Serum, Dayton, USAB. Serrata ExtractReduces lines and wrinkles.
LANCER—Soothe and Hydrate Serum, Beverly hills, USAB. Serrata ExtractImproves skin redness while balancing skin tone.
Mitomo—Hyaluronic Acid + Lithospermum Facial Essence Mask, Tokyo, JapanB. Serrata ExtractBrightening, moisturizing, and refining.
Skin Actives—Collagen Serum, Chandler, USAB. Serrata ExtractHelps improve skin tone and texture.
Kate Somerville—Liquid Exfolikate, Moreno Valley, California, USAB. Serrata ExtractSoothes skin.
Yadah—Anti-T Mist, Seoul, KoreaB. Serrata ExtractRevitalize and smoothens skin.
New Vitality Lumatone—Anti-Aging Eye Cream, New York, USAB. Serrata Extract Antiaging.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Alraddadi, B.G.; Shin, H.-J. Biochemical Properties and Cosmetic Uses of Commiphora myrrha and Boswellia serrata. Cosmetics 2022, 9, 119. https://doi.org/10.3390/cosmetics9060119

AMA Style

Alraddadi BG, Shin H-J. Biochemical Properties and Cosmetic Uses of Commiphora myrrha and Boswellia serrata. Cosmetics. 2022; 9(6):119. https://doi.org/10.3390/cosmetics9060119

Chicago/Turabian Style

Alraddadi, Bssmah Ghazi, and Hyun-Jae Shin. 2022. "Biochemical Properties and Cosmetic Uses of Commiphora myrrha and Boswellia serrata" Cosmetics 9, no. 6: 119. https://doi.org/10.3390/cosmetics9060119

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop